Detalhe da pesquisa
1.
Recruitment Strategies of a Decentralized Randomized Placebo Controlled Clinical Trial: The Canagliflozin Impact on Health Status, Quality of Life and Functional Status in Heart Failure (CHIEF-HF) Trial.
J Card Fail
; 29(6): 863-869, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37040839
2.
Association of Recent Use of Non-Vitamin K Antagonist Oral Anticoagulants With Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Treated With Alteplase.
JAMA
; 327(8): 760-771, 2022 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35143601
3.
Efficacy of a centralized, blended electronic, and human intervention to improve direct oral anticoagulant adherence: Smartphones to improve rivaroxaban ADHEREnce in atrial fibrillation (SmartADHERE) a randomized clinical trial.
Am Heart J
; 237: 68-78, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33676886
4.
Association Between Wearable Device Measured Activity and Patient-Reported Outcomes for Heart Failure.
JACC Heart Fail
; 11(11): 1521-1530, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37498273
5.
The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial.
Nat Med
; 28(4): 809-813, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35228753
6.
Screening for postpartum depression in a pediatric emergency department.
Pediatr Emerg Care
; 27(9): 795-800, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21878826
7.
Novel Trial Design: CHIEF-HF.
Circ Heart Fail
; 14(3): e007767, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33724883
8.
Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program.
Clin Infect Dis
; 36(2): 159-68, 2003 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12522747
9.
Clinical experience with linezolid for the treatment of nocardia infection.
Clin Infect Dis
; 36(3): 313-8, 2003 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12539073
10.
Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections.
Clin Pharmacokinet
; 43(13): 925-42, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15509186
11.
Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programme.
Clin Pharmacokinet
; 42(15): 1411-23, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-14674791
12.
Population pharmacokinetics of linezolid in patients treated in a compassionate-use program.
Antimicrob Agents Chemother
; 47(2): 548-53, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12543657
13.
The efficacy and safety of linezolid as treatment for Staphylococcus aureus infections in compassionate use patients who are intolerant of, or who have failed to respond to, vancomycin.
J Antimicrob Chemother
; 50(6): 1017-26, 2002 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-12461026